INTERNATIONAL PATENT: INTAS PHARMACEUTICALS LTD. FILES APPLICATION FOR "METHOD FOR IMPROVING GALACTOSYLATION PROFILE AND REDUCING OXIDIZED SPECIES IN PRODUCTION OF PEMBROLIZUMAB"

GENEVA, July 2 -- INTAS PHARMACEUTICALS LTD. (Corporate House, Near Sola Bridge,S. G. Highway, Thaltej, Ahmedabad - 380054,Gujarat, India.Ahmedabad 380054) filed a patent application (PCT/IB2024/062691) for "METHOD FOR IMPROVING GALACTOSYLATION PROFILE AND REDUCING OXIDIZED SPECIES IN PRODUCTION OF PEMBROLIZUMAB" on Dec 16, 2024. With publication no. WO/2025/133873, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHOPDA, Viki (Intas Pharmaceuticals Limited - Biopharma Division,Plot No: 423/P/A/GIDC, Vill: MoraiyaSarkhej-B...